Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2002
06/19/2002EP1215202A1 Intermediates for the preparation of possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-(4.3.0)-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
06/19/2002EP1214322A2 Amino-triazolopyridine derivatives
06/19/2002EP1214321A1 Process for production of naphthyridine-3-carboxylic acid derivatives
06/19/2002EP1214320A1 Pyrido-pyridazine derivatives as ligands for gaba receptors
06/19/2002EP1214319A1 Imidazo-pyridine derivatives as ligands for gaba receptors
06/19/2002EP1214318A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives
06/19/2002EP1214314A2 Aminopiperidine derivatives as antibacterials
06/19/2002EP1214292A1 Tyrosine derivatives
06/19/2002CN1354751A Bicyclic polyaminoacid metal complexes, method for preparing same and use in medical imaging
06/19/2002CN1354750A Amine derivatives compounds
06/19/2002CN1354663A Sulfonamide and sulfamide substituted imidazoquinolines
06/19/2002CN1354182A Preparation process of sophora alopecuroides series alkaloid salts substances
06/19/2002CN1354181A Preparation process of oxysophocarpine
06/19/2002CN1354180A Preparation process of oxysophoridine
06/19/2002CN1354179A Preparation process of sophoridine
06/19/2002CN1086386C Multi-drug resistance modifier
06/18/2002US6407254 For organic polymers
06/18/2002US6407241 Reacting the corresponding with amine and phosgene; cyclization; therapy for bone disorders; antiinflammatory agents
06/18/2002US6407240 Reduction of the corresponding ester; reacting with iminium salt
06/18/2002US6407118 Antitumor agents; side effect reduction
06/18/2002US6407116 2,4-dioxo-1,2,3,4-tetrahydroquinazoline derivatives; antiallergens, antiasthmatics, antihistamines, and antiinflammatory agents
06/18/2002US6407112 2a,3,4,5-tetrahydro-1h-benz(cd)indol-2-one derivatives; 5-hydroxytryptamine agonists; sleep, circadian rhythym, bipolar, and psychological disorder treatment
06/18/2002US6407108 1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them
06/18/2002US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
06/18/2002US6407095 Treating nicotinic receptor, gastrointestinal, nervous system, psychological, and brain disorders
06/18/2002US6407092 Tetracyclic azepinoindole compounds
06/18/2002US6407089 Triazatrinaphthyrins and the use thereof
06/18/2002CA2241725C Growth-hormone secretagogues
06/18/2002CA2057786C Amino and nitro containing tricyclic compounds useful as inhibitors or ace
06/18/2002CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
06/13/2002WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha
06/13/2002WO2002046314A2 Perylene pigment compositions
06/13/2002WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors
06/13/2002WO2002046194A2 Substituted imidazopyridines
06/13/2002WO2002046193A2 Heterocyclic ether substituted imidazoquinolines
06/13/2002WO2002046192A2 Thioether substituted imidazoquinolines
06/13/2002WO2002046191A2 Urea substituted imidazoquinoline ethers
06/13/2002WO2002046190A2 Sulfonamido ether substituted imidazoquinolines
06/13/2002WO2002046189A2 Aryl ether substituted imidazoquinolines
06/13/2002WO2002046188A2 Amido ether substituted imidazoquinolines
06/13/2002WO2002046187A1 Analgesic diazabicyclo[4.3.0]nonanes
06/13/2002WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/13/2002WO2002046158A2 Piperidine/piperazine-type inhibitors of p38 kinase
06/13/2002WO2002030906B1 Anti-tumour compounds
06/13/2002WO2002024686A3 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives
06/13/2002WO2002020012A3 Method for treating allergies using substituted pyrazoles
06/13/2002WO2002020011A3 A method for treating allergies using substituted pyrazoles
06/13/2002WO2002014315A3 Substituted pyrazoles
06/13/2002WO2002000657A3 Condensed pyrazindione derivatives
06/13/2002US20020072607 Inhibit binding of integrins to their ligands and are of use in prophylaxis and therapy of of immune or inflammatory disorders, or disorders including inappropriate growth or migration of cells
06/13/2002US20020072606 Chemokine receptor antagonists
06/13/2002US20020072604 For prophylaxis and therapy of obesity, diabetes, sexual disorders, eating disorder; for modulating appetite and metabolic rates; for stimulating appetite of livestock for treatment of ketosis, postpartum anestrus
06/13/2002US20020072602 Micronized mirtazapine
06/13/2002US20020072525 Aryl fused azapolycyclic compounds
06/13/2002US20020072524 Aryl fused azapolycyclic compounds
06/13/2002US20020072523 For therapy of inflammatory and immune diseases
06/13/2002US20020072519 Useful as psychotherapeutic agents
06/13/2002US20020072518 Bicyclic alphavbeta3 antagonists
06/13/2002CA2436984A1 Urea substituted imidazoquinoline ethers
06/13/2002CA2436983A1 Sulfonamido ether substituted imidazoquinolines
06/13/2002CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/13/2002CA2431187A1 Macroheterocylic compounds useful as kinase inhibitors
06/13/2002CA2431151A1 Heterocyclic ether substituted imidazoquinolines
06/13/2002CA2431040A1 Substituted imidazopyridines
06/13/2002CA2430844A1 Aryl ether substituted imidazoquinolines
06/13/2002CA2430206A1 Screening method for identifying compounds that selectively induce interferon alpha
06/13/2002CA2429258A1 Piperidine/piperazine-type inhibitors of p38 kinase
06/12/2002EP1213281A1 Novel amide derivatives
06/12/2002EP1212486A1 Chlorohydrin and cationic compounds having high affinity for pulp or paper
06/12/2002EP1212330A1 Androgen receptor modulator compounds and methods
06/12/2002EP1212323A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
06/12/2002EP1212322A2 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators
06/12/2002EP1212321A2 Intermediates for the production of naphthyridine-3-carboxylic acid derivatives
06/12/2002EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
06/12/2002EP1212103A1 4-fluoroalkyl-3-halophenyl nortropanes
06/12/2002EP1178972A4 Novel synthesis of piperazine ring
06/12/2002EP1023287B1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors
06/12/2002EP0885221B1 Azabicyclic esters of carbamic acids useful in therapy
06/12/2002EP0776324B1 Endothelin antagonists
06/12/2002CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof
06/12/2002CN1353694A Alpha-substituted carboxylic acid derivatives
06/12/2002CN1353693A Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors
06/12/2002CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds
06/12/2002CN1353609A Amide substituted imidazoquinolines
06/12/2002CN1353606A IL-8 receptor antagonists
06/12/2002CN1086188C Novel phenanethridinium derivatives
06/11/2002US6403808 Treating mental disorders
06/11/2002US6403632 Cyclic amide derivative
06/11/2002US6403603 Antitumor agent
06/11/2002US6403592 Serotonin reuptake inhibitors
06/11/2002US6403591 1-azatricyclic-4-benzylpiperazines
06/11/2002US6403588 Imidazopyridine derivatives
06/11/2002US6403587 Autoimmune diseases, acute and chronic inflammatory conditions, allergic conditions, infection associated with inflammation, viral, transplantation tissue rejection, atherosclerosis, restenosis, hiv infectivity, and
06/11/2002US6403583 Anticoagulant agents for treatment and prevention of thromboembolic disorders.
06/11/2002US6403532 Herbicidal synergistic composition, and method of controlling weeds
06/11/2002US6402829 Heating aqueous slurry
06/11/2002CA2262692C Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives
06/11/2002CA2169838C Antipsychotic method
06/06/2002WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors
06/06/2002WO2002044177A2 Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine